Currently holds positions in Spectrum Pharmaceuticals Inc and Recro Pharma Inc
Position | Company | Period |
---|---|---|
Independent Chairman of the Board | Spectrum Pharmaceuticals Inc | June 19, 2019 - |
Independent Director | Recro Pharma Inc | Jan. 1, 2009 - |
Independent Director | Spectrum Pharmaceuticals Inc | Feb. 23, 2018 - June 19, 2019 |
Independent Director | Sellas Life Sciences Group Inc | April 26, 2013 - Dec. 29, 2017 |
Independent Director | Sucampo Pharmaceuticals Inc | Oct. 15, 2009 - May 29, 2015 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-08-28 | 2023-08-28 |
Recro Pharma Inc
(REPH)
|
B Purchase |
22,222
+9.2%
0.4610,111 USD |
22,222 +9.2% | 0.46 | 10,111 USD | |
2022-06-22 | 2022-06-21 |
Spectrum Pharmaceuticals Inc
(SPPI)
|
PS Planned sale |
4,283
-9.1%
0.793,362 USD |
4,283 -9.1% | 0.79 | 3,362 USD | |
2020-06-23 | 2020-06-22 |
Spectrum Pharmaceuticals Inc
(SPPI)
|
PS Planned sale |
5,000
-10.7%
3.2516,250 USD |
5,000 -10.7% | 3.25 | 16,250 USD | |
2019-06-21 | 2019-06-20 |
Spectrum Pharmaceuticals Inc
(SPPI)
|
PS Planned sale |
1,667
-20.0%
8.5014,170 USD |
1,667 -20.0% | 8.50 | 14,170 USD | |
2019-06-21 | 2019-06-19 |
Spectrum Pharmaceuticals Inc
(SPPI)
|
PS Planned sale |
5,000
-37.5%
8.5942,950 USD |
5,000 -37.5% | 8.59 | 42,950 USD |